+247.2%
ARM vs MRNA
+260.4%
-13.2%
-62.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.6% | -6.8% | +4.2% | -2.1% |
| 7D | -10.4% | +9.8% | -20.2% | -10.9% |
| 30D | -31.8% | +11.5% | -43.3% | -32.3% |
| 3M | -32.2% | +319.4% | -351.6% | -41.9% |
| 6M | -14.9% | +361.5% | -376.4% | -29.6% |
| YTD | +66.0% | +750.6% | -684.5% | +18.3% |
| 1Y | +17.2% | +913.0% | -895.8% | -20.5% |
| 3Y | +247.2% | +258.1% | -10.9% | +141.7% |
| All | +247.2% | +260.4% | -13.2% | +141.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling